Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.Operating system Therapies will definitely provide on the NYSE American stock swap today using a $6...

ALX's fizzling CD47 response fee sends stock spiraling down

.ALX Oncology's stage 2 stomach cancer action price has actually deteriorated. After observing its C...

Ionis axes eye disease coming from aim ats of Roche-partnered possibility after data dissatisfy

.An Additional of Ionis Pharmaceuticals' key midphase readouts has disappointed assumptions, trigger...

Biogen's CEO pointed out no unsafe handle 2023. He's ready to be bold

.While Biogen's pharma peers are actually searching for late-stage resources along with little bit o...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Biography has been actually a biotech seeking a pipeline after it scrapped its lead properti...

Biogen walks away from Denali Alzheimer's collab

.Biogen has handed back legal rights to an early Alzheimer's ailment course to Denali Therapeutics, ...

Takeda water faucets brand-new head people oncology business-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings a...

Vertex, beaten through AATD again, goes down 2 assets on discard heap

.Tip's effort to deal with an unusual hereditary ailment has actually struck an additional trouble. ...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Medical's second-quarter profits report wasn't except large headlines. The provider welcomed a ...

Galapagos stops briefly CAR-T cell treatment litigation over Parkinsonism scenario

.Galapagos has stopped application in a test of a BCMA-directed CAR-T cell treatment, pushing the br...